A national education program for pharmacists funded by the Australian Government under the Quality Use of Diagnostics, Therapeutics and Pathology program.[/caption]
While the evidence bases for both CMs and Schedule 3 sleep aids are unlikely to immediately change, a core practice consideration is the risk-benefit profile of the respective non-prescription sleep aids for the individual patient. 
Is it really insomnia?
Knowledge to practice 
Ensuring patients’ medical data is secure
The rollout of My Health Record has raised questions surrounding the security of medical data. What measures must be taken in pharmacies to preserve...
Why pharmacists should be embedded in healthcare teams
The Pharmaceutical Society of Australia’s (PSA) Pharmacists in 2023 report found that the inclusion of pharmacists in healthcare teams will ensure that medicines are used...
Community pharmacy effective in reducing prescribing waste
An English project looking to reduce medicines wastage across community pharmacy, care homes and general practice has produced savings representing a return of nearly...
What the Government’s new health plan means for pharmacy
The Department of Health recently released its reform plan for healthcare: Australia’s Long Term National Health Plan: to build the world’s best health system....
Vale FIP President Dominique Jordan
Tributes have been paid to International Pharmaceutical Federation President Mr Dominique Jordan, who sadly passed away on 19 August.
Patrick Reid extended interview
I've been lobbying pretty hard for a long time as both a pharmacist and the CEO of a large aged-care provider for pharmacists to...
